Evidence map›Paper›PMID 40661963›Full record

ArticlePediatric quality & safety

Assessment of a Stepwise Intervention to Improve Nurse-administered Penicillin Allergy Screening and De-labeling in Pediatric Inpatients.

Victoria J L Konold, Filmon Emnetu, Daniel Pak, Gabriel Mendoza, Adam W Brothers, Derry McDonald, Hector Valdivia, Scott J Weissman, Matthew P Kronman, Lori Rutman and 1 more

Abstract read
In one paragraph

Article in Pediatric quality & safety. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Victoria J L KonoldFrom the Division of Infectious Diseases, Department of Pediatrics, University of Washington, Seattle, Wash.
Filmon EmnetuEli Lilly and Company, Clinical Development-Cardiometabolic Health.
Daniel PakDepartment of Pharmacy, Seattle Children's Hospital, Seattle, Wash.
Gabriel MendozaDivision of Allergy and Infectious Diseases, University of Washington, Seattle, Wash.
Adam W BrothersDepartment of Pharmacy, Seattle Children's Hospital, Seattle, Wash.
Derry McDonaldDepartment of Pharmacy, Seattle Children's Hospital, Seattle, Wash.
Hector ValdiviaDepartment of Nursing Practice, Seattle Children's Hospital, Seattle, Wash.
Scott J WeissmanFrom the Division of Infectious Diseases, Department of Pediatrics, University of Washington, Seattle, Wash.
Matthew P KronmanFrom the Division of Infectious Diseases, Department of Pediatrics, University of Washington, Seattle, Wash.
Lori RutmanDivision of Emergency Medicine, Department of Pediatrics, University of Washington, Seattle, Wash.
Karyn YonekawaDivision of Nephrology, Department of Pediatrics, University of Washington, Seattle, Wash.

Funding

Omics and Symptom Science Training ProgramT32NR016913 · NINR · UNIVERSITY OF WASHINGTON · PI CYNTHIA M DOUGHERTY, Margaret McLean Heitkemper · 2017 to 2026
$3.2M
NINR NIH HHS T32 NR016913
6 · The paper itself

Abstract

Introduction: Penicillins are first-line treatments for many childhood infections, but providers avoid them when patients report a penicillin allergy, although approximately 94% of these patients may tolerate penicillin. Patients with penicillin allergy labels often receive second-line antibiotics, which increases the risk of treatment failure and adverse events. To address this, programs to implement penicillin allergy de-labeling have increased; however, strategies to accomplish de-labeling most efficiently through guideline dissemination have not been well-studied. Methods: A multidisciplinary team created an evidence-based screening algorithm and standard protocol to screen eligible pediatric inpatients and de-label documented penicillin allergies. Plan-do-study-act cycles identified opportunities for improvement to the standard protocol. Results: We developed a screening tool to assess the risk of penicillin allergy and integrated it into the electronic health record for administration by clinical nurses. Follow-up actions, including de-labeling or further testing, are automatically communicated to the provider. Nurse-initiated screening increased from 3.8% to 28.1% after adding an electronic "worklist task" reminder. Allergy de-labeling demonstrated special cause variation following the dissemination of a standardized amoxicillin challenge order set and then again after a brief period of audit and feedback; however, the increases were not sustained. Conclusions: A nurse-administered screening questionnaire and protocolized follow-up actions can help achieve safe de-labeling at hospitals without a dedicated penicillin allergy service.

Identifiers

PMID40661963
PMCPMC12259212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.